Stay updated on Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMelanoma is added as a topic and MedlinePlus Genetics is listed as related topics. The page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check22 days agoChange DetectedMinor revision update from v3.4.0 to v3.4.1; no changes to study content, data, or page functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision: v3.4.0. Removed older/duplicate metadata terms (Last Update Submitted that met QC Criteria, No FEAR Act data) and related references (e.g., MedlinePlus Genetics).SummaryDifference0.3%

- Check44 days agoChange DetectedRemoved related topics Melanoma and MedlinePlus Genetics, and added Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as related topics on the study page.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a Locations section listing New South Wales, Queensland, and Victoria, and updated the page revision to v3.3.3. Removed separate state location subpages (New South Wales Locations, Queensland Locations, Victoria Locations) and withdrew certain footer/related-topic links (HHS Vulnerability Disclosure, Melanoma, MedlinePlus Genetics).SummaryDifference0.5%

Stay in the know with updates to Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.